Precalence study on ICU Treatment of COVID-19 patients in Northern and Western Saxony in the first half of 2020 - PraeCoSa

Precalence study on ICU Treatment of COVID-19 patients in Northern and Western Saxony in the first half of 2020 - PraeCoSa - PraeCoSa

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021705

Enrollment

100

Registered

2020-08-03

Start date

2020-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J12.8 J80.09

Interventions

Group 1: retrospective data analysis of patients with COVID-19 treated in an intensive care unit and management of ressources of the hospitals

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: positive SARS-CoV-2 test result and Treatment in an intensive care unit in the period of January to June 2020

Exclusion criteria

Exclusion criteria: age < 18y

Design outcomes

Primary

Measure	Time frame
length of stay in the intensive care unit and survival with retrospective analysis and entering in the electronical case report form	—

Secondary

Measure	Time frame
Management of ressources, infection prevention of staff and other patients	—

Countries

Germany

Contacts

Public ContactChristian Seeber

Klinik für Anästhesiologie und IntensivtherapieUniversitätsklinikum Leipzig

christian.seeber@medizin.uni-leipzig.de0341 97 17700

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026